SMMT

NASD Summit Therapeutics Inc

Oct 26, 2026 · 8:44 AM ET LAST TRADE Market Closed

$15.56 ↑ +0.09 (+0.58%) Trading Up from the previous close of $15.47

YTD change: -11.03%
vs 20-day SMA: -4.48%
vs 200-day SMA: -4.17%

Price ranges

Previous day

$15.08 $15.55

open $15.46 close $15.47

+$0.01 (+0.06%)

Today

$0.00 $0.00

$15.56

Past week

$14.63 $16.35

from $14.63 now $15.56

+$0.93 (+6.36%)

Past month

$14.56 $19.09

from $15.61 now $15.56

-$0.05 (-0.32%)

This year

$12.07 $29.23

from $17.49 now $15.56

-$1.93 (-11.03%)

Price & Performance

-6.65 (-30.06%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 57.8% away from all-time highs of $36.91
SMMT is down 11% since the beginning of the year
SMMT is down 19% over the past 12 months
SMMT is down 0% over the past 1 month
27% of all SMMT investors are betting against SMMT

SMMT reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -20.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.28

Earnings momentum +0.2% Quarterly EPS growth

Quarterly change +0.2%

Valuation

P/E ratio N/A

Enterprise value $11.4B

Beta 1.10

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$691.0M

Debt$20.4K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $12.4B

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Competitor comparison

Ticker	Company	Price	Change
CSLLY	CSL Limited Sponsored ADR	$34.60	+0.58%
ARGX	argenx SE Sponsored ADR	$873.71	-0.23%
ONC	BeOne Medicines Ltd. Sponsored ADR	$377.63	-1.21%
WXIBF	Wuxi Biologics (Cayman) Inc.	$6.32	+18.35%
INCY	Incyte Corporation	$115.71	-1.04%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.